Immunocore (NASDAQ:IMCR) Receives “Equal Weight” Rating from Morgan Stanley
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “equal weight” rating reiterated by equities research analysts at Morgan Stanley in a note issued to investors on Friday,Benzinga reports. They presently have a $35.00 target price on the stock. Morgan Stanley’s price target would suggest a potential upside of 17.45% from the stock’s current price. […]
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “equal weight” rating reiterated by equities research analysts at Morgan Stanley in a note issued to investors on Friday,Benzinga reports. They presently have a $35.00 target price on the stock. Morgan Stanley’s price target would suggest a potential upside of 17.45% from the stock’s current price. […]
